Cano Health, Inc.
CANO
CANO was delisted on the 2nd of February, 2024.
130 hedge funds and large institutions have $1.43B invested in Cano Health, Inc. in 2021 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 32 closing their positions.
151% more call options, than puts
Call options by funds: $36.7M | Put options by funds: $14.6M
63% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 32
27% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 30
18% more funds holding
Funds holding: 110 → 130 (+20)
24% less capital invested
Capital invested by funds: $1.89B → $1.43B (-$462M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$56.7M |
| 2 |
SC
Samlyn Capital
New York
|
+$40.2M |
| 3 |
Amundi
Paris,
France
|
+$16.4M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$15.3M |
| 5 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.8M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$16.2M |
| 3 |
Renaissance Technologies
New York
|
-$15.1M |
| 4 |
DCP
Diameter Capital Partners
New York
|
-$13.5M |
| 5 |
Millennium Management
New York
|
-$13.3M |
CANO Hedge Fund Activity: Q4 2021 in Review
130 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q4 2021, worth a combined $1.43B — down 24% from $1.89B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new CANO positions and 32 closed out — a net gain of 20 holders — while 38 added to existing stakes and 30 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $56.7M. The largest seller was Fidelity Investments, cutting an estimated $30.8M.
- 130 institutional investors held Cano Health, Inc. (CANO) as of Q4 2021, up from 110 in Q3 2021.
- Funds reported $1.43B of Cano Health, Inc. stock for Q4 2021, down 24% quarter-over-quarter.
- 52 funds opened new Cano Health, Inc. positions in Q4 2021 and 32 closed out, a net change of +20 holders.
- The largest Cano Health, Inc. buyer in Q4 2021 was JP Morgan Chase, an estimated $56.7M added.
- The largest Cano Health, Inc. seller in Q4 2021 was Fidelity Investments, an estimated $30.8M sold.
Based on aggregated 13F filings for Q4 2021.